Eribulin: a new treatment option in metastatic breast cancer heavily pretreated?

被引：0
|
作者：
Goncalves, Anthony
机构：
来源：
BULLETIN DU CANCER | 2011年 / 98卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [1] Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
    Menis, J.
    Twelves, C.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 101 - 111
  • [2] Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
    Sabatier, Renaud
    Martin, Johan
    Vicier, Cecile
    Guerin, Mathilde
    Monneur, Audrey
    Provansal, Magali
    Tassy, Louis
    Tarpin, Carole
    Extra, Jean-Marc
    Viret, Frederic
    Goncalves, Anthony
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 10
  • [3] Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
    Ates, Ozturk
    Babacan, Taner
    Kertmen, Neyran
    Sarici, Furkan
    Cenoli, Alma
    Akin, Serkan
    Karakas, Yusuf
    Kilickap, Saadettin
    Ozisik, Yavuz
    Sever, Ali R.
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF BUON, 2016, 21 (02): : 375 - 381
  • [4] Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life
    Sari, Murat
    Saip, Pinar
    INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 55 - 61
  • [5] Long-term treatment with eribulin in heavily pretreated women with metastatic breast cancer: a case series
    Morritti, Maria
    Iodice, Giuseppe
    Melaccio, Assunta
    D'Onofrio, Loretta
    Bergnolo, Paola
    Boglione, Antonella
    Comandone, Alessandro
    Molinaro, Peppina
    Garigliano, Danula
    FUTURE ONCOLOGY, 2017, 13 (11) : 25 - 33
  • [6] A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
    Aogi, K.
    Iwata, H.
    Masuda, N.
    Mukai, H.
    Yoshida, M.
    Rai, Y.
    Taguchi, K.
    Sasaki, Y.
    Takashima, S.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1441 - 1448
  • [7] Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.
    Ates, Ozturk
    Babacan, Taner
    Sarici, Furkan
    Kertmen, Neyran
    Cenoli, Alma
    Akin, Serkan
    Karakas, Yusuf
    Kilickap, Saadettin
    Aksoy, Sercan
    Ozisik, Yavuz Yasin
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
    Pedersini, Rebecca
    Vassalli, Lucia
    Claps, Melanie
    Tulla, Antonella
    Rodella, Filippo
    Grisanti, Salvatore
    Amoroso, Vito
    Roca, Elisa
    Simoncini, Edda Lucia
    Berruti, Alfredo
    ONCOLOGY, 2018, 94 : 10 - 15
  • [9] Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
    Philippe Aftimos
    Ahmad Awada
    Advances in Therapy, 2011, 28 : 973 - 985
  • [10] Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
    Aftimos, Philippe
    Awada, Ahmad
    ADVANCES IN THERAPY, 2011, 28 (11) : 973 - 985
12345